Data / Research funding / New Jersey / RBHS -Cancer Institute of New Jersey
RBHS -Cancer Institute of New Jersey: 46 NIH awards ($46.7M), fiscal years 2021 to 2026
RBHS -Cancer Institute of New Jersey in New Brunswick, NJ is funded under 46 NIH awards ($46.7M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- QL3ZB67MLJL5
- State
- New Jersey
Awards
46 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Cancer Center Support Grant | NIH | National Cancer Institute | 2021 to 2022 | $9,532,839 | March 1, 1997 | February 28, 2023 | LIBUTTI, STEVEN K. | reporter.nih.gov |
| Mechanisms of the BRCA-network in tumorigenesis and therapeutic response | NIH | National Cancer Institute | 2021 to 2022 | $4,555,101 | May 1, 2021 | April 30, 2023 | SHEN, ZHIYUAN | reporter.nih.gov |
| SEER CORE INFRASTRUCTURE SUPPORT | NIH | National Cancer Institute | 2021 to 2023 | $3,897,106 | March 3, 2021 | April 30, 2024 | STROUP, ANTOINETTE | reporter.nih.gov |
| Developing bone morphogenetic receptor II inhibitors for the treatment of cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,375,957 | July 6, 2018 | June 30, 2024 | LANGENFELD, JOHN | reporter.nih.gov |
| Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment | NIH | National Cancer Institute | 2021 to 2022 | $1,285,821 | May 1, 2019 | April 30, 2023 | GANESAN, SHRIDAR | reporter.nih.gov |
| A Multi-Level Investigation of US Indoor Tanning PolicyEnactment, Implementation, Compliance, Impact, and Economics | NIH | National Cancer Institute | 2021 to 2022 | $1,278,872 | June 1, 2020 | May 31, 2023 | HECKMAN, CAROLYN | reporter.nih.gov |
| Impact of mutation burden on cancer growth and the immune landscape | NIH | National Cancer Institute | 2021 to 2022 | $1,277,605 | December 1, 2019 | November 30, 2022 | GANESAN, SHRIDAR | reporter.nih.gov |
| Bright IDEAS-Young Adults: Problem-Solving Skills Training to Reduce Distress among Young Adults with Cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,274,845 | April 15, 2020 | March 31, 2023 | DEVINE, KATIE A | reporter.nih.gov |
| A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate Cancer | NIH | National Cancer Institute | 2021 to 2022 | $1,271,825 | August 1, 2018 | July 31, 2023 | PASQUALINI, RENATA | reporter.nih.gov |
| Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survivor Trial | NIH | National Cancer Institute | 2021 to 2022 | $1,264,000 | March 15, 2020 | February 28, 2023 | MANNE, SHARON L | reporter.nih.gov |
| Facebook Intervention for Young Onset Melanoma Patients and Families | NIH | National Cancer Institute | 2021 to 2022 | $1,057,165 | June 1, 2018 | May 31, 2025 | MANNE, SHARON L | reporter.nih.gov |
| Gain-of-function mutant p53 and metabolic reprogramming in colorectal cancer | NIH | National Cancer Institute | 2021 to 2022 | $890,528 | April 1, 2021 | March 31, 2023 | HU, WENWEI | reporter.nih.gov |
| The regulation of mutant p53 protein accumulation in cancer: molecular basis and therapeutic potential | NIH | National Cancer Institute | 2021 to 2022 | $823,103 | July 1, 2021 | June 30, 2023 | FENG, ZHAOHUI | reporter.nih.gov |
| Molecular modulators of radiation-induced chromosome instability and hematopoietic damage | NIH | National Cancer Institute | 2021 to 2022 | $743,092 | May 1, 2015 | June 30, 2023 | SHEN, ZHIYUAN | reporter.nih.gov |
| TELEhealth Shared decision-making COaching for lung cancer screening in Primary care (TELESCOPE) | NIH | National Heart, Lung, and Blood Institute | 2022 | $736,380 | April 1, 2022 | March 31, 2023 | KINNEY, ANITA Y. | reporter.nih.gov |
| The role of glutaminolysis as a therapeutic target in T-ALL | NIH | National Cancer Institute | 2021 to 2022 | $727,426 | July 1, 2019 | June 30, 2023 | HERRANZ, DANIEL | reporter.nih.gov |
| Elucidate the mechanism of autophagy in supporting Lkb1-deficient lung tumorigenesis and metastasis | NIH | National Cancer Institute | 2021 to 2022 | $724,612 | February 1, 2020 | January 31, 2023 | GUO, YANXIANG | reporter.nih.gov |
| Metabolic reprogramming in breast cancer | NIH | National Cancer Institute | 2021 to 2022 | $720,151 | March 1, 2018 | February 29, 2024 | FENG, ZHAOHUI | reporter.nih.gov |
| Functional Targeting of the Tyrosine Kinase EphA5 in Radiation-resistant Lung Cancer | NIH | National Cancer Institute | 2021 to 2022 | $720,151 | June 4, 2018 | May 31, 2024 | PASQUALINI, RENATA | reporter.nih.gov |
| Computational approaches for identifying epigenomic contexts of somatic mutations | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $715,500 | April 1, 2019 | March 31, 2023 | DE, SUBHAJYOTI | reporter.nih.gov |
| Designing a transcriptome-based, targeted theranostic platform for prostate cancer | NIH | National Cancer Institute | 2021 to 2022 | $710,140 | March 15, 2020 | February 28, 2023 | PASQUALINI, RENATA | reporter.nih.gov |
| Regulation of Ku70 methylation and functions by SETD4 | NIH | National Cancer Institute | 2021 to 2022 | $710,140 | February 1, 2021 | January 31, 2023 | SHEN, ZHIYUAN | reporter.nih.gov |
| Regulation of DNA replication kinetics by BRCA2 after DNA damage | NIH | National Cancer Institute | 2021 to 2022 | $682,649 | July 1, 2021 | June 30, 2023 | XIA, BING | reporter.nih.gov |
| Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL | NIH | National Cancer Institute | 2021 | $682,392 | September 17, 2018 | August 31, 2022 | COLE, PETER D. | reporter.nih.gov |
| Metabolic Control and Anticancer Mechanism | NIH | National Cancer Institute | 2021 to 2022 | $675,499 | July 1, 2021 | June 30, 2023 | ZHENG, STEVEN | reporter.nih.gov |
| A digital intervention to improve skin self-examination among melanoma survivors | NIH | National Cancer Institute | 2022 | $664,230 | April 1, 2022 | March 31, 2023 | MANNE, SHARON L | reporter.nih.gov |
| Comparative Effectiveness of Interventions to Increase Guideline-based Genetic Counseling in Ethnically and Geographically Diverse Cancer Survivors | NIH | National Cancer Institute | 2021 | $618,436 | December 22, 2016 | November 30, 2023 | KINNEY, ANITA Y. | reporter.nih.gov |
| Biobehavioral Effects of Qigong for Prostate Cancer Survivors with Fatigue | NIH | National Cancer Institute | 2021 | $614,473 | December 9, 2016 | November 30, 2023 | KINNEY, ANITA Y. | reporter.nih.gov |
| A Multilevel Approach to Cardiovascular Health in African American Breast Cancer Survivors: from Neighborhoods to Metabolomics | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2022 | $486,122 | August 14, 2018 | May 31, 2025 | QIN, BO | reporter.nih.gov |
| Mechanisms of targeting cellular self-renewal in glioblastoma | NIH | National Cancer Institute | 2021 | $485,837 | July 2, 2018 | June 30, 2022 | SABAAWY, HATIM | reporter.nih.gov |
| Discovery and therapeutic targeting of biological determinants of lung cancer health disparities | NIH | National Cancer Institute | 2021 to 2022 | $480,903 | May 15, 2020 | June 30, 2022 | PINE, SHARON R. | reporter.nih.gov |
| Modifying Young Adult Skin Cancer Risk and Protective Behaviors (UV4.me2):A Hybrid Type 2 Dissemination/Effectiveness Trial | NIH | National Cancer Institute | 2021 | $480,695 | December 1, 2016 | November 30, 2023 | HECKMAN, CAROLYN | reporter.nih.gov |
| Post-doctoral Training Program in Cancer Metabolism and Tumor-host Interactions | NIH | National Cancer Institute | 2021 to 2022 | $462,031 | April 1, 2021 | March 31, 2023 | ZONG, WEI-XING | reporter.nih.gov |
| Hepatitis B virus integrations in KMT2B drive hepatocellular carcinoma | NIH | National Cancer Institute | 2022 | $453,403 | July 15, 2022 | June 30, 2023 | CAO, JIAN | reporter.nih.gov |
| Genomic Instability-Induced Senescence in Brain Aging and Alzheimer's Disease | NIH | National Institute on Aging | 2025 | $432,280 | September 30, 2020 | March 31, 2026 | MONTAGNA, CRISTINA | reporter.nih.gov |
| Role of PALB2 in the DNA Damage Response and Cancer Suppression | NIH | National Cancer Institute | 2021 | $424,655 | July 1, 2009 | June 30, 2022 | XIA, BING | reporter.nih.gov |
| Amino Acids-Rab1A Nutrient Signaling in the Regulation of Glucose Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 | $382,677 | September 18, 2020 | July 31, 2022 | ZHENG, STEVEN | reporter.nih.gov |
| The role of leukemia inhibitory factor in colorectal cancer | NIH | National Cancer Institute | 2022 | $372,497 | February 1, 2022 | January 31, 2023 | HU, WENWEI | reporter.nih.gov |
| Targeting Lymphatic Vessels for Ligand Directed Imaging | NIH | National Cancer Institute | 2021 | $363,713 | December 1, 2016 | November 30, 2022 | PASQUALINI, RENATA | reporter.nih.gov |
| SENP6, a novel p53 negative regulator, is an important new player in cancer | NIH | National Cancer Institute | 2021 | $363,713 | July 1, 2018 | June 30, 2022 | FENG, ZHAOHUI | reporter.nih.gov |
| The role of chronic stress in regulation of mutant p53 and tumorigenesis | NIH | National Cancer Institute | 2021 | $363,306 | January 1, 2017 | December 31, 2022 | HU, WENWEI | reporter.nih.gov |
| Rutgers Youth Enjoy Science (RUYES) program | NIH | National Cancer Institute | 2021 | $353,147 | September 1, 2020 | November 30, 2022 | CHAUDHARY, SUNITA | reporter.nih.gov |
| CANCAN-RUTGERS | NIH | National Cancer Institute | 2022 | $223,182 | June 22, 2022 | May 31, 2023 | WHITE, EILEEN P. | reporter.nih.gov |
| Inference of tumor growth dynamics using genomic data | NIH | National Cancer Institute | 2021 | $183,202 | May 15, 2020 | April 30, 2023 | DE, SUBHAJYOTI | reporter.nih.gov |
| Developing and testing a mobile health intervention to promote sun protection behaviors and skin examination among Hispanics | NIH | National Institute on Minority Health and Health Disparities | 2022 | $125,955 | April 15, 2022 | January 31, 2023 | NIU, ZHAOMENG | reporter.nih.gov |
| The Feasibility of a Medical Student Mentoring Program to Improve Transition of Care Among Adolescents with Sickle Cell Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $45,355 | September 10, 2018 | May 15, 2022 | VIOLA, ADRIENNE | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 1 | $432,280 | 0 | $0 |
| 2023 | 1 | $1,239,985 | 0 | $0 |
| 2022 | 33 | $21,199,784 | 0 | $0 |
| 2021 | 39 | $23,840,662 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed) | PAR-27-088 | NIH | 93.396 | November 20, 2026 | Not listed | Same assistance listing 93.396 as 16 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.396 | December 4, 2026 | Not listed | Same assistance listing 93.396 as 16 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.396 | January 7, 2027 | $375,000 | Same assistance listing 93.396 as 16 awards here |
| Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) | PAR-25-221 | NIH | 93.396 | January 7, 2027 | Not listed | Same assistance listing 93.396 as 16 awards here |
| Single Source: Coordinating Center (CC) for the Small Cell Lung Cancer (SCLC) Consortium (U24 Clinical Trial Not Allowed) | PAR-27-009 | NIH | 93.396 | January 25, 2027 | Not listed | Same assistance listing 93.396 as 16 awards here |
| Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) | RFA-CA-28-013 | NIH | 93.396 | February 9, 2027 | $700,000 | Same assistance listing 93.396 as 16 awards here |
| New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional) | PAR-25-272 | NIH | 93.396 | May 7, 2027 | Not listed | Same assistance listing 93.396 as 16 awards here |
| New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional) | PAR-25-279 | NIH | 93.396 | May 7, 2027 | Not listed | Same assistance listing 93.396 as 16 awards here |
| Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | RFA-CA-28-003 | NIH | 93.396 | June 11, 2027 | $600,000 | Same assistance listing 93.396 as 16 awards here |
| Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) | PA-24-254 | NIH | 93.396 | July 12, 2027 | Not listed | Same assistance listing 93.396 as 16 awards here |
| Successor-in-Interest (Type 6 Parent Clinical Trial Optional) | PA-24-253 | NIH | 93.396 | July 17, 2027 | Not listed | Same assistance listing 93.396 as 16 awards here |
| NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) | PA-25-080 | NIH | 93.396 | September 7, 2027 | Not listed | Same assistance listing 93.396 as 16 awards here |
| Investigator-Focused Award (Parent R35) | PAR-28-037 | NIH | 93.396 | October 4, 2027 | Not listed | Same assistance listing 93.396 as 16 awards here |
| Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) | RFA-CA-27-019 | NIH | 93.396 | October 19, 2027 | $300,000 | Same assistance listing 93.396 as 16 awards here |
| NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) | PA-25-301 | NIH | 93.396 | January 7, 2028 | Not listed | Same assistance listing 93.396 as 16 awards here |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed) | PA-25-304 | NIH | 93.396 | January 7, 2028 | Not listed | Same assistance listing 93.396 as 16 awards here |
| NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required) | PA-25-306 | NIH | 93.396 | January 7, 2028 | Not listed | Same assistance listing 93.396 as 16 awards here |
| Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) | PAR-24-311 | NIH | 93.396 | January 7, 2028 | $500,000 | Same assistance listing 93.396 as 16 awards here |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) | PAR-25-043 | NIH | 93.396 | January 7, 2028 | $500,000 | Same assistance listing 93.396 as 16 awards here |
| Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed) | PAR-25-044 | NIH | 93.396 | January 7, 2028 | Not listed | Same assistance listing 93.396 as 16 awards here |
Topics of its NIH awards
- Cancer
- Genetics
- Prevention
- Clinical Research
- Behavioral and Social Science
- Women's Health
- Health Disparities
- Minority Health
- Rare Diseases
- Clinical Trials and Supportive Activities
- Biotechnology
- Pediatric
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.